Skip to main content
. 2022 Aug 25;2022(8):CD013751. doi: 10.1002/14651858.CD013751.pub2

3.9. Analysis.

3.9

Comparison 3: Hypoxia‐inducible factor (HIF) stabiliser versus erythropoiesis‐stimulating agent (ESA), Outcome 9: Fatal or nonfatal hospitalisation for heart failure